Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: Effect of neuroinflammation

Molecular Pharmaceutics

Volumn 10, Issue 12, 2013, Pages 4560-4571

  Lesniak, Wojciech G ^a   Mishra, Manoj K ^a   Jyoti, Amar ^a   Balakrishnan, Bindu ^a   Zhang, Fan ^a   Nance, Elizabeth ^a   Romero, Roberto ^b   Kannan, Sujatha ^a   Kannan, Rangaramanujam M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DHHS   (United States)

Author keywords

biodistribution; brain uptake quantification; cellular imaging; cerebral palsy; neuroinflammation; PAMAM dendrimer; pharmacokinetics

Indexed keywords

CYANINE DYE; POLYAMIDOAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; BRAIN; CEREBRAL PALSY; CONJUGATE; CONJUGATION; CONTROLLED STUDY; EXCRETION; EXPERIMENTAL RABBIT; FEMALE; FLUORESCENCE SPECTROSCOPY; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; KIDNEY; KIDNEY CLEARANCE; LIVER; LUNG; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; ORGAN DISTRIBUTION; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM; SYNTHESIS; URINE;

ANIMALS; CARBOCYANINES; CEREBRAL PALSY; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; RABBITS; TISSUE DISTRIBUTION;

EID: 84889241223     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400371r     Document Type: Article

References (41)

1. Lee, C. C.; Gillies, E. R.; Fox, M. E.; Guillaudeu, S. J.; Fréchet, J. M.; Dy, E. E.; Szoka, F. C. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas Proc. Natl. Acad. Sci. U.S.A. 2006, 7 103 (45) 16649-16654 (Pubitemid 44737307)
2. Kukowska-Latallo, J. F.; Candido, K. A.; Cao, Z.; Nigavekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. R., Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 2005, 65, 5317-5324 (Pubitemid 40827344)
3. Khan, M. K.; Minc, D. L.; Nigavekar, S. S.; Kariapper, M. T. S.; Nair, B. M.; Schipper, M.; Cook, C. A.; Lesniak, W. G.; Balogh, L. P. Fabrication of radioactive gold/dendrimer composite nanodevices and their use for nano-brachytherapy Nanomed. Nanotechnol. 2008, 4 (1) 57-69
4. 3 integrins Bioconjugate Chem. 2007, 18 (4) 1148-1154 (Pubitemid 47122636)
5. Venditto, V. J.; Regino, C. A.; Brechbiel, M. W. PAMAM dendrimer based macromolecules as improved contrast agents Mol. Pharmaceutics 2005, 2 (4) 302-311 (Pubitemid 41186406)
6. Wang, X.; Cai, X.; Hu, J.; Shao, N.; Wang, F.; Zhang, Q.; Xiao, J.; Cheng, Y. Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles J. Am. Chem. Soc. 2013, 135, 9805-9810
7. Shukla, R.; Thomas, T. P.; Peters, J. L.; Desai, A. M.; Kukowska-Latallo, J.; Patri, A. K.; Kotlyar, A.; Baker, J. R., Jr. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb Bioconjugate Chem. 2006, 17 (5) 1109-1115 (Pubitemid 44455317)
8. Majoros, I. J.; Myc, A.; Thomas, T.; Mehta, C. B.; Baker, J. R., Jr. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 2006, 7 (2) 572-579
9. Patil, M. L.; Zhang, M.; Taratula, O.; Garbuzenko, O. B.; He, H.; Minko, T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting Biomacromolecules 2009, 10 (2) 258-66
10. Talanov, V. S.; Regino, C. A.; Kobayashi, H.; Bernardo, M.; Choyke, P. L.; Brechbiel, M. W. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging Nano Lett. 2006, 6 (7) 1459-1463 (Pubitemid 44195328)
11. Thommey, T. P.; Sascha, N.; Majoros, I. J.; Kotlyar, A.; Cao, Z.; Leroueil, P. R.; Baker, J. R., Jr. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis Arth. Rheum. 2011, 63 (9) 2671-2680
12. Chandrasekar, D.; Sistla, R.; Ahmad, F. J.; Khar, R. K.; Diwan, P. V. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats Biomaterials 2007, 3 (28) 504-512 (Pubitemid 44602223)
13. Kannan, S.; Dai, H.; Navath, R. S.; Balakrishnan, B.; Jyoti, A.; Janisse, J.; Romero, R.; Kannan, R. M. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model Sci. Trans. Med. 2012, 4 (130) 130-146
14. Iezzi, R.; Guru, B. R.; Glybina, I. V.; Mishra, M. K.; Kennedy, A.; Kannan, R. M. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration Biomaterials 2012, 33 (3) 979-988
15. Dai, H.; Navath, R. S.; Balakrishnan, B.; Guru, B. R.; Mishra, M. K.; Romero, R.; Kannan, R. M.; Kannan, S. Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration Nanomedicine 2010, 5 (9) 1317-1329
16. Shaunak, S.; Thomas, S.; Gianasi, E.; Godwin, A.; Jones, E.; Teo, I.; Mireskandari, K.; Luthert, P.; Duncan, R.; Patterson, S.; Khaw, P.; Brocchini, S. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation Nat. Biotechnol. 2004, 22, 977-984 (Pubitemid 39014474)
17. Kim, I. D.; Shin, J. H.; Kim, S. W.; Choi, S.; Ahn, J.; Han, P. L.; Park, J. S.; Lee, J. K. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain Mol. Ther. 2012, 20 (4) 829-39
18. Mishra, M.; Kotta, K.; Hali, M.; Wykes, S.; Benchaala, I.; Gerard, H.; Hudson, A.; Whittum-Hudson, J.; Kannan, R. M. PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis Infections Nanomedicine 2011, 7 (6) 935-944
19. Bosnjakovic, A.; Mishra, M.; Ren, W.; Kurtoglu, Y. E.; Kannan, R. M. Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation Nanomedicine 2010, 7 (3) 284-294
20. Chauhan, A. S.; Diwan, P. V.; Jain, N. K.; Tomalia, D. A. Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers Biomacromolecules 2009, 11 (5) 1195-202
21. Medina, S. H.; Tiruchinapally, G.; Chevliakov, M. V.; Durmaz, Y. Y.; Stender, R. N.; Ensminger, W. D.; Shewach, D. S.; Elsayed, M. E. Targeting hepatic cancer cells with PEGylated dendrimers displaying N-acetylgalactosamine and SP94 peptide ligands Adv. Healthcare Mater. 2013, 2, 1337-1350
22. Kasturirangan, V.; Nair, B. M.; Kariapper, M. T.; Lesniak, W. G.; Tan, W.; Bizimungu, R.; Kanter, P.; Toth, K.; Buitrago, S.; Rustum, Y. M.; Hutson, A.; Balogh, L. P.; Khan, M. K. In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges Nanotoxicology 2013, 7 (4) 441-51
23. Nair, B. M.; Kariapper, M. T. S.; Lesniak, W. G.; Tan, W.; Hutson, A.; Khan, M. K.; Balogh, L. P. Toxicity evaluation of gold-dendrimer composite nanodevices in vitro-difference found between tumor and proliferating endothelial cells Nanotoxicology 2009, 3 (2) 139-151
24. Mager, E. D.; Mody, V.; Xu, C.; Forrest, A.; Lesniak, W. G.; Nigavekar, S. S.; Kariapper, T. M.; Minc, L.; Khan, M. K.; Balogh, L. P. Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition Pharm. Res. 2012, 29 (9) 2534-2542
25. Khan, M. K.; Nigavekar, S. S.; Kariapper, M. S. T.; Nair, B. M.; Lesniak, W. G.; Balogh, L. P. Host-guest nanodevices: in vivo biodistribution of dendrimers and dendrimer nanocomposites-implications for cancer imaging and therapy Technol. Cancer Res. Treat. 2005, 4 (6) 603-613 (Pubitemid 43083344)
26. Balogh, L.; Nigavekar, S. S.; Nair, B. M.; Lesniak, W.; Zhang, C.; Sung, L. Y.; Kariapper, M. S.; El-Jawahri, A.; Llanes, M.; Bolton, B.; Mamou, F.; Tan, W.; Hutson, A.; Minc, L.; Khan, M. K. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models Nanomedicine 2007, 3 (4) 281-296 (Pubitemid 350199641)
27. Sadekar, S.; Ray, A.; Janàt-Amsbury, M.; Peterson, C. M.; Ghandehari, H. Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice Biomacromolecules 2011, 12 (1) 88-96
28. 125I-labelled polyamidoamine dendrimers in vivo J. Controlled Release 2000, 65 (1-20) 133-148 (Pubitemid 30122922)
29. Kojima, C.; Regino, C.; Umeda, Y.; Kobayashi, H.; Kono, K. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers Int. J. Pharmaceutics 2010, 383 (1-2) 293-296
30. Nigavekar, S. S.; Sung, L. Y.; Llanes, M.; El-Jawahri, A.; Lawrence, T. S.; Becker, C. W.; Balogh, L.; Khan, M. K. 3H dendrimer nanoparticle organ/tumor distribution Pharm. Res. 2004, 21 (3) 476-483
31. Li, Y.; He, H.; Jia, X.; Lu, W. L.; Lou, J.; Wei, Y. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas Biomaterials 2012, 33 (15) 3899-908
32. Kannan, S.; Saadani-Makki, F.; Balakrishnan, B.; Chakraborty, P.; Janisse, J.; Lu, X.; Muzik, O.; Romero, R.; Chugani, D. C. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure Dev. Neurosci. 2011, 33 (3-4) 231-40
33. Klajnert, B.; Sadowska, M.; Bryszewska, M. Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin Bioelectrochemistry 2004, 55 (1-2) 23-26
34. Shcharbin, D.; Klajnert, B.; Mazhul, V.; Bryszewska, M. J. Dendrimer interactions with hydrophobic fluorescent probes and human serum albumin J. Fluoresc. 2005, 15 (1) 21-28 (Pubitemid 40536202)
35. Klajnert, B.; Bryszewska, M. Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin Bioelectrochemistry 2002, 55, 33-35 (Pubitemid 34084746)
36. Kobayashi, H.; Kawamoto, S.; Jo, S. K.; Sato, N.; Saga, T.; Hiraga, A.; Konishi, J.; Hu, S.; Togashi, K.; Brechbiel, M. W. Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent Kidney Int. 2002, 61 (6) 1980-1985 (Pubitemid 34539315)
37. Dear, J. W.; Kobayashi, H.; Brechbiel, M. W.; Star, R. A. Imaging acute renal failure with polyamine dendrimer-based MRI contrast agents Nephron. Clin. Pract. 2006, 103 (2) c45-c49
38. van Rooy, I.; Cakir-Tascioglu, S.; Hennink, W. E.; Storm, G.; Schiffelers, R. M.; Mastrobattista, E. In vivo methods to study uptake of nanoparticles into the brain Pharm. Res. 2011, 28 (3) 456-71
39. Calvo, P.; Gouritin, B.; Villarroya, H.; Eclancher, F.; Giannavola, C.; Klein, C.; Andreux, J. P.; Couvreur, P. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat Eur. J. Neurosci. 2002, 15 (8) 1317-26 (Pubitemid 35477993)
40. Nance, E. A.; Woodworth, G. F.; Sailor, K. A.; Shih, T. Y.; Xu, Q.; Swaminathan, G.; Xiang, D.; Eberhart, C.; Hanes, J. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 2012, 4 (149) 149-119
41. Sena, L. M.; Fishman, S. J.; Jenkins, K. J.; Xu, H.; Brechbiel, M. W.; Regino, C. A.; Kosaka, N.; Bernardo, M.; Choyke, P. L; Kobayashi, H. Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models Nanomedicine 2010, 5 (8) 1183-1191